Related Experiment Videos
Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve
G Perdikaris1, H Giamarellou, A Pefanis
11st Department of Propedeutic Medicine, Athens University School of Medicine, Laiko General Hospital, Greece.
Antimicrobial Agents and Chemotherapy
|October 1, 1995
Summary
Vancomycin monotherapy effectively treats experimental aortic valve endocarditis caused by resistant Staphylococcus aureus. Adding netilmicin or rifampin did not improve outcomes, though longer treatment courses showed a trend toward better efficacy.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Aortic valve endocarditis is a severe infection often caused by Staphylococcus aureus.
- Emergence of antibiotic-resistant strains, like methicillin- and gentamicin-resistant Staphylococcus aureus (MGRSA), necessitates evaluating effective treatment strategies.
- Rabbit models are crucial for studying endocarditis pathogenesis and antibiotic efficacy.
Purpose of the Study:
- To evaluate the efficacy of vancomycin alone and in combination with netilmicin and/or rifampin against MGRSA in a rabbit model of aortic valve endocarditis.
- To determine if combination therapy offers improved outcomes compared to vancomycin monotherapy.
- To assess the impact of treatment duration on therapeutic success.
Main Methods:
- A rabbit model of aortic valve endocarditis was established using MGRSA.
- Animals received various antibiotic regimens: vancomycin alone, vancomycin plus netilmicin, vancomycin plus rifampin, and vancomycin plus netilmicin plus rifampin.
- Different dosages and durations (6-12 days) of antibiotic administration were employed.
- Vegetation bacterial counts were assessed to determine treatment efficacy compared to controls.
Main Results:
- All tested antibiotic regimens, except netilmicin alone, significantly reduced bacterial counts in vegetations compared to untreated controls.
- Vancomycin monotherapy demonstrated efficacy comparable to the triple combination therapy.
- Addition of netilmicin (once daily or twice daily) to vancomycin did not enhance efficacy, even when combined with rifampin.
- No development of resistance to rifampin or netilmicin was observed during the study.
- A 12-day treatment course showed a trend towards greater effectiveness than a 6-day course, though not statistically significant.
Conclusions:
- Vancomycin monotherapy is a viable and effective treatment for experimental aortic valve endocarditis caused by MGRSA.
- Combination therapy with netilmicin and/or rifampin does not provide additional benefit over vancomycin monotherapy in this model.
- Optimizing treatment duration may play a role in improving outcomes for MGRSA endocarditis.